A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors

Author： Nock Charles Brell Joanna Bokar Joseph Cooney Matthew Cooper Brenda Gibbons Joseph Krishnamurthi Smitha Manda Sudhir Savvides Panayiotis Remick Scot Ivy Percy Dowlati Afshin

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.29, Iss.1, 2011-02, pp. : 126-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors

By Hubbard Joleen Erlichman Charles Toft David Qin Rui Stensgard Bridget Felten Sara Ten Eyck Cynthia Batzel Gretchen Ivy S. Haluska Paul

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 473-480

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors

By Deming Dustin Ninan Jacob Bailey Howard Kolesar Jill Eickhoff Jens Reid Joel Ames Matthew McGovern Renee Alberti Dona Marnocha Rebecca Espinoza-Delgado Igor Wright John Wilding George Schelman William

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 323-329

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

By Richter Suzanne Bedard Philippe Chen Eric Clarke Blaise Tran Ben Hotte Sebastien Stathis Anastasios Hirte Hal Razak Albiruni Reedijk Michael Chen Zhuo Cohen Brenda Zhang Wen-Jiang Wang Lisa Ivy S. Moore Malcolm Oza Amit Siu Lillian McWhirter Elaine

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 243-249

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Trial of the Polyamine Analog N¹,N¹⁴-Diethylhomospermine (DEHSPM) in Patients with Advanced Solid Tumors

By Wilding George King David Tutsch Kendra Pomplun Marcia Feierabend Chris Alberti Dona Arzoomanian Rhoda

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 131-138

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of continuous infusion cilengitide in patients with solid tumors

By O'Donnell Peter

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 604-610

Springer Publishing Company

Access to resources Recommend Favorite